BONUS: Doctor Shorts: Dr. Melissa Young discusses Insulin Resistance, Ozempic & Mounjaro

Resources for the Community:
___________________________________________________________________

https://linktr.ee/theplussidezpodcast 

Ro - Telehealth for GLP1 weight management 

https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55

______________________________________________________________________

**The Provider Spotlight is a new bonus series of shorter episodes featuring doctors and specialists from past sessions—think of it as 'doctor shorts.' With over 25k scripts for Zepbound written weekly, many new subscribers haven't seen our earlier episodes, which helps them catch up quickly. Thanks for your support!

Dr. Young first joined us in Season 1. She is an endocrinologist who often treats the disease of obesity and insulin resistance.  She will explain the role of hormones in obesity and type 2 diabetes and discuss the spectrum of insulin resistance. Additionally, she will cover how GLP-1s like Ozempic or Mounjaro can provide endocrine therapy for both obesity and type 2 diabetes.

Dr. Melissa Young
TikTok @MadEndo
______________________________________________________________________

⭐️Mounjaro Stanley⭐️

griffintumblerco.Etsy.com

Use code PODCAST10 for $ OFF
______________________________________________________________________

Join this channel to get access to perks:

   / @theplussidez

______________________________________________________________________

#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy 

Send us Fan Mail!

Use Honest Care to Appeal GLP-1 Denials. Go to HonestCare.com/Kim 

Support the show

Kim Carlos, Executive Producer 

TikTok

Instagram 

Kat Carter,  Producer 

TikTok

Instagram